- 17 June
-
From May 20 to 22, the first Eurasian International Medical Forum was held in Ekaterinburg. The event was dedicated to the 80th anniversary of Victory in the Great Patriotic War. The Forum brought together over 1,000 participants and 250 experts from Russia, India, China and Belarus. Medsintez Plant took an active part in scientific program of the Forum and demonstrated its latest developments in the field of import-substituting drugs.
- 13 June
-
The X (XXXI) National Diabetes Congress with international participation was held in Moscow from May 27 to 30, 2025. The event was dedicated to the topic «Diabetes mellitus – a non-infectious pandemic of the 21st century. Macro- and microvascular complications. Issues of interdisciplinary interaction». The Congress was dedicated to the 100th anniversary of the Russian Association of Endocrinologists, the Endocrinology Service of the Russian Federation and the Research Center for Endocrinology.
- 10 June
-
In May 2025, pharmaceutical plant Medsintez Plant LLC joined the leading enterprises that were awarded the status of National Champion based on the results of a comprehensive expert selection. Getting the status of National Champion is a significant event for Medsintez Plant, which emphasizes its contribution to the development of the pharmaceutical industry and strengthening the drug safety of Russia.
- 25 April
-
From April 15 to 18, Ekaterinburg hosted the 6th international specialized exhibition and forum Healthcare of the Urals–2025. This year, 130 companies from 34 cities of Russia and the Republic of Belarus took part in the event, presenting over 1000 units of medical equipment and goods. The residents of the Ural Biomedical Cluster were traditionally among the participants, as well as its collective member – the Association of Medical and Pharmaceutical Manufacturers of the Sverdlovsk Region.
- Home
- Cluster members
- Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC
Nipro PharmaPackaging Ural LLC is a 100% subsidiary of NIPRO (Japan).
The company is engaged in manufacture of primary glass packaging for pharmaceutical industry.
Ampoules, vials, cartridges are made exclusively of a glass tube of the 1st hydrolytic class Type I, in accordance with European, American, Japanese pharmacopoeias, of the following brands: NSV51 (manufacturer – Nipro PharmaPackaging), Fiolax (manufacturer Schott), FS5.0 (manufacturer Four Stars, China), JUNHENG (manufacturer – Triumph Junheng, China), Corning-51-D (China).
The range of products manufactured by the company includes:
• Ampoules: 1 to 25 ml, forms B, C, D, E; made of clear and amber glass, with open point cut or cut ring, in accordance with ISO 9187 It is possible to apply marker rings to the ampoules.
• Vials: 1 to 30 ml, made of clear and amber glass, with a crimp neck, in accordance with ISO 8362
• Cartridges with a nominal capacity of 1.5; 1.8; 3 ml; made of clear glass in accordance with ISO 13926
Technological lines are equipped with options for printing on products, which allows you to apply a company logo or other information, for additional protection of medicines against counterfeiting.
In addition to standard products, the company is capable to manufacture products in accordance with individual customer drawings.
otal production capacity is up to 300 million items per year. The plant is equipped with the latest equipment: European made ampoule and vial lines by OCMI (Italy), Euromatic (Italy), NCE (Belgium), a cartridge lines of own production by NIPRO (France). All technological lines are equipped with automated quality control systems VIMEC (Netherlands), which allows rejecting products for geometric, cosmetic and mechanical defects.
The company implemented a quality management system certified in accordance with ISO 9001:2015, ISO 15378 (Special requirements for ISO 9001:2008 implementation, taking into account Good Manufacturing Practice GMP).
Ilya Markovsky,
Director
+7 (912) 242-74-99
